Incidence of severe urinary tract infections not increased by initiating sodium-glucose cotransporter 2 inhibitors.
作者信息
Yokoyama Hiroki
机构信息
Jiyugaoka Medical Clinic, Internal Medicine, Obihiro, Japan.
出版信息
J Diabetes Investig. 2020 May;11(3):530-531. doi: 10.1111/jdi.13189. Epub 2020 Jan 7.
Abstract
摘要
相似文献
1
Incidence of severe urinary tract infections not increased by initiating sodium-glucose cotransporter 2 inhibitors.启动钠-葡萄糖协同转运蛋白2抑制剂不会增加严重尿路感染的发生率。
J Diabetes Investig. 2020 May;11(3):530-531. doi: 10.1111/jdi.13189. Epub 2020 Jan 7.
2
Risk factors for urinary tract infections among nursing home residents initiating sodium-glucose cotransporter-2 inhibitors.开始使用钠-葡萄糖协同转运蛋白2抑制剂的疗养院居民发生尿路感染的危险因素。
J Am Geriatr Soc. 2024 Sep;72(9):2878-2881. doi: 10.1111/jgs.19029. Epub 2024 Jun 8.
3
Impact of sodium-glucose cotransporter-2 inhibitors-induced glucosuria in the incidence of urogenital infection on postmenopausal women with diabetes.钠-葡萄糖共转运蛋白 2 抑制剂致糖尿对绝经后女性糖尿病患者泌尿生殖道感染发生率的影响。
Postgrad Med. 2020 Nov;132(8):697-701. doi: 10.1080/00325481.2020.1816360. Epub 2020 Oct 5.
4
Sodium-Glucose Cotransporter 2 Inhibitors and Mycotic Genital or Urinary Tract Infections in Heart Failure.钠-葡萄糖共转运蛋白 2 抑制剂与心力衰竭患者的真菌性生殖器或尿路感染。
J Card Fail. 2024 Aug;30(8):1031-1040. doi: 10.1016/j.cardfail.2024.04.009. Epub 2024 Apr 25.
5
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study.钠-葡萄糖共转运蛋白 2 抑制剂与严重尿路感染风险：一项基于人群的队列研究。
Ann Intern Med. 2019 Aug 20;171(4):248-256. doi: 10.7326/M18-3136. Epub 2019 Jul 30.
6
Sodium-Glucose Cotransporter 2 Inhibitors and Urinary Tract Infection: Is There Room for Real Concern?钠-葡萄糖共转运蛋白 2 抑制剂与尿路感染：是否有真正值得关注的地方？
Kidney360. 2022 Sep 12;3(11):1991-1993. doi: 10.34067/KID.0005722022. eCollection 2022 Nov 24.
7
[Urinary tract infections in patients with type 2 diabetes mellitus with pharmacological glucosuria].2型糖尿病合并药物性糖尿患者的尿路感染
Ter Arkh. 2020 Dec 26;92(11):106-109. doi: 10.26442/00403660.2020.11.000581.
8
Reply to: The risk for genito-urinary infections with sodium-glucose cotransporter-2 inhibitors: duration rather than dose matter?回复：钠-葡萄糖协同转运蛋白2抑制剂导致泌尿生殖系统感染的风险：持续时间而非剂量起关键作用？
Expert Rev Clin Pharmacol. 2024 Aug;17(8):765. doi: 10.1080/17512433.2024.2367101. Epub 2024 Jun 12.
9
Sodium-glucose cotransporter-2 inhibitors increase urinary tract infections?-a cross sectional analysis of a nationwide Japanese claims database.钠-葡萄糖共转运蛋白 2 抑制剂是否会增加尿路感染？-一项基于全国日本理赔数据库的横断面分析。
Endocr J. 2023 Nov 28;70(11):1103-1107. doi: 10.1507/endocrj.EJ23-0317. Epub 2023 Sep 6.
10
Use of sodium-glucose cotransporter-2 inhibitors and urinary tract infections in type 2 diabetes patients: a systematic review.2型糖尿病患者中钠-葡萄糖协同转运蛋白2抑制剂的使用与尿路感染：一项系统评价
Rev Assoc Med Bras (1992). 2019 Feb;65(2):246-252. doi: 10.1590/1806-9282.65.2.246.
引用本文的文献
1
SGLT2 Inhibitors and the Risk of Urogenital Infections: A Concise Review.钠-葡萄糖协同转运蛋白2抑制剂与泌尿生殖系统感染风险：简要综述
J Clin Med. 2025 Mar 14;14(6):1960. doi: 10.3390/jcm14061960.
2
Emphysematous Cystitis and Urinary Retention in a Male Patient With Diabetes Mellitus Type 2 Treated With Empagliflozin.恩格列净治疗的2型糖尿病男性患者并发气肿性膀胱炎和尿潴留
AACE Clin Case Rep. 2022 Apr 8;8(4):163-165. doi: 10.1016/j.aace.2022.04.002. eCollection 2022 Jul-Aug.
本文引用的文献
1
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study.钠-葡萄糖共转运蛋白 2 抑制剂与严重尿路感染风险：一项基于人群的队列研究。
Ann Intern Med. 2019 Aug 20;171(4):248-256. doi: 10.7326/M18-3136. Epub 2019 Jul 30.
2
Incidence and risk of vaginal candidiasis associated with sodium-glucose cotransporter 2 inhibitors in real-world practice for women with type 2 diabetes.真实世界中 2 型糖尿病女性应用钠-葡萄糖共转运蛋白 2 抑制剂与阴道念珠菌病的发生风险及相关性。
J Diabetes Investig. 2019 Mar;10(2):439-445. doi: 10.1111/jdi.12912. Epub 2018 Oct 19.
3
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.钠-葡萄糖共转运蛋白 2 抑制剂对 2 型糖尿病成人患者心血管事件、死亡和主要安全性结局的影响：系统评价和荟萃分析。
Lancet Diabetes Endocrinol. 2016 May;4(5):411-9. doi: 10.1016/S2213-8587(16)00052-8. Epub 2016 Mar 18.
4
Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus. The Manitoba Diabetic Urinary Infection Study Group.糖尿病女性无症状菌尿的患病率及相关宿主因素。曼尼托巴糖尿病泌尿系统感染研究组。
Clin Infect Dis. 1995 Aug;21(2):316-22. doi: 10.1093/clinids/21.2.316.
Zotero 插件